As genomic profiling did not provide conclusive evidence for biallelic mutation as common cause of SMARCB1 inactivation, which is typical for rhabdoid tumors, we next investigated DNA methylation as an alternative mechanism for gene silencing. This evidence concerns the gene SMARCB1 and rhabdoid tumor.